ArticleMethods in molecular biology (Clifton, N.J.)2025
Isolation and Purification of Adipocyte-Derived Extracellular Vesicles (AdEVs) Using Size-Exclusion Chromatography.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Engineered exosomes for targeted glioma therapy: overcoming the blood-brain barrier with nature-inspired nanocarriers.Discover nano · 2026Review
- The role and prospects of extracellular vesicles in advanced drug and vaccine delivery.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adipocyte-derived extracellular vesicles (AdEVs), like other types of extracellular vesicles (EVs), are released from their donor parental cells in varying sizes and large quantities. During this process, diverse cargos are often internalized in the lumen or covalently attached on the surface of these EVs, allowing for their horizontal transfer from adipocytes to non-adipocyte cells. Hence, AdEVs can promote the ability of adipocytes to remodel the tumor microenvironment in cancers affecting, among others, breast and colon tissues by acting as mediators of cell-to-cell communication through the release of bioactive molecules. Cancer-associated adipocytes, for instance, can promote tumor growth, metastasis, and therapeutic resistance by secreting AdEVs carrying oncogenic microRNAs, cytokines, and chemokines, which interact with signaling pathways (e.g., JAK/STAT3 and PI3K/AKT) that lead to tumor formation and cancerous behavior. As the importance of EVs in these processes rapidly gains attention, a reliable method of isolating AdEVs also becomes highly essential. Therefore, this chapter describes the use of size-exclusion chromatography given its ability to preserve vesicle integrity and achieve high sample purity.
Indexed as
Identifiers
40445289What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.